Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches.
Mariot V, Joubert R, Hourdé C, Féasson L, Hanna M, Muntoni F, Maisonobe T, Servais L, Bogni C, Le Panse R, Benvensite O, Stojkovic T, Machado PM, Voit T, Buj-Bello A, Dumonceaux J.
Mariot V, et al. Among authors: joubert r.
Nat Commun. 2017 Nov 30;8(1):1859. doi: 10.1038/s41467-017-01486-4.
Nat Commun. 2017.
PMID: 29192144
Free PMC article.